{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:45:45Z","timestamp":1791895545173,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Previous studies have shown less access to deep brain stimulation (DBS) for Parkinson\u2019s disease (PD) in women compared to men raising concerns about a potential gender gap resulting from nonclinical factors or gender differences in clinical efficacy for postoperative quality of life (QoL), motor, and nonmotor symptoms (NMS) outcomes. This was a cross-sectional and a longitudinal, prospective, observational, controlled, quasi-experimental, international multicenter study. A total sample size of 505 consisted of 316 consecutively referred patients for DBS indication evaluation at the University Hospital Cologne (01\/2015\u201309\/2020) and 189 consecutively treated patients at DBS centers in the University Hospitals Cologne and Marburg, Salford\u2019s Royal Hospital Manchester, and King\u2019s College Hospital London. In the cross-sectional cohort, we examined gender proportions at referral, indication evaluations, and DBS surgery. In the longitudinal cohort, clinical assessments at preoperative baseline and 6-month follow-up after surgery included the PD Questionnaire-8, NMSScale, Scales for Outcomes in PD-motor scale, and levodopa-equivalent daily dose. Propensity score matching resulted in a pseudo-randomized sub-cohort balancing baseline demographic and clinical characteristics between women with PD and male controls. 316 patients were referred for DBS. 219 indication evaluations were positive (women <jats:italic>n<\/jats:italic>\u2009=\u2009102, respectively <jats:italic>n<\/jats:italic>\u2009=\u200982). Women with PD were disproportionally underrepresented in referrals compared to the general PD population (relative risk [RR], 0.72; 95%CI, 0.56\u20130.91; <jats:italic>P<\/jats:italic>\u2009=\u20090.002), but more likely to be approved for DBS than men (RR, 1.17; 95%CI, 1.03\u20131.34; <jats:italic>P<\/jats:italic>\u2009=\u20090.029). Nonetheless, their total relative risk of undergoing DBS treatment was 0.74 (95%CI, 0.48\u20131.12) compared to men with PD. At baseline, women had longer disease duration and worse dyskinesia. Exploring QoL domains, women reported worse mobility and bodily discomfort. At follow-up, all main outcomes improved equally in both genders. Our study provides evidence of a gender gap in DBS for PD. Women and men with PD have distinct preoperative nonmotor and motor profiles. We advocate that more focus should be directed toward the implementation of gender equity as both genders benefit from DBS with equal clinical efficacy. This study provides Class II evidence of beneficial effects of DBS in women with PD compared to male controls.<\/jats:p>","DOI":"10.1038\/s41531-022-00305-y","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T10:03:14Z","timestamp":1650448994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Gender gap in deep brain stimulation for Parkinson\u2019s disease"],"prefix":"10.1038","volume":"8","author":[{"given":"Stefanie T.","family":"Jost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rizos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-2156","authenticated-orcid":false,"given":"Philipp A.","family":"Loehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyoumars","family":"Ashkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8230-1856","authenticated-orcid":false,"given":"Gereon R.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sauerbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-9410","authenticated-orcid":false,"given":"Christopher","family":"Nimsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar","family":"Sattari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2815-0505","authenticated-orcid":false,"given":"K.","family":"Ray Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-2807","authenticated-orcid":false,"given":"Angelo","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Martinez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monty","family":"Silverdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Kalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Visser-Vandewalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8849-4233","authenticated-orcid":false,"given":"Haidar S.","family":"Dafsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson\u2019s Disease Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"305_CR1","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1205158","volume":"368","author":"WM Schuepbach","year":"2013","unstructured":"Schuepbach, W. M. et al. Neurostimulation for Parkinson\u2019s disease with early motor complications. N. Engl. J. Med. 368, 610\u2013622 (2013).","journal-title":"N. Engl. J. Med."},{"key":"305_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41531-021-00174-x","volume":"7","author":"ST Jost","year":"2021","unstructured":"Jost, S. T. et al. Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease. NPJ Parkinsons Dis. 7, 48 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"305_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa060281","volume":"355","author":"G Deuschl","year":"2006","unstructured":"Deuschl, G. et al. A randomized trial of deep-brain stimulation for Parkinson\u2019s disease. N. Engl. J. Med. 355, 896\u2013908 (2006).","journal-title":"N. Engl. J. Med."},{"key":"305_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/jnnp-2019-322614","volume":"91","author":"ST Jost","year":"2020","unstructured":"Jost, S. T. et al. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson\u2019s disease: results at the 36-month follow-up. J. Neurol. Neurosurg. Psychiatry 91, 687\u2013694 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"305_CR5","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1007\/s00415-020-09743-1","volume":"267","author":"HS Dafsari","year":"2020","unstructured":"Dafsari, H. S. et al. Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson\u2019s disease. J. Neurol. 267, 1830\u20131841 (2020).","journal-title":"J. Neurol."},{"key":"305_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3233\/JPD-212823","volume":"12","author":"SP Anna","year":"2022","unstructured":"Anna, S. P. et al. The New Satisfaction with Life and Treatment Scale (SLTS-7) in Patients with Parkinson\u2019s Disease. J. Parkinson Dis. 12, 453\u2013464 (2022).","journal-title":"J. Parkinson Dis."},{"key":"305_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","volume":"87","author":"F Moisan","year":"2016","unstructured":"Moisan, F. et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J. Neurol. Neurosurg. Psychiatry 87, 952\u2013957 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"305_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/ner.12973","volume":"22","author":"DS Shpiner","year":"2019","unstructured":"Shpiner, D. S. et al. Gender Disparities in Deep Brain Stimulation for Parkinson\u2019s Disease. Neuromodulation 22, 484\u2013488 (2019).","journal-title":"Neuromodulation"},{"key":"305_CR9","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1001\/archneurol.2011.151","volume":"68","author":"M Katz","year":"2011","unstructured":"Katz, M., Kilbane, C., Rosengard, J., Alterman, R. L. & Tagliati, M. Referring patients for deep brain stimulation: an improving practice. Arch. Neurol. 68, 1027\u20131032 (2011).","journal-title":"Arch. Neurol."},{"key":"305_CR10","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00415-016-8384-9","volume":"264","author":"M Picillo","year":"2017","unstructured":"Picillo, M. et al. The relevance of gender in Parkinson\u2019s disease: a review. J. Neurol. 264, 1583\u20131607 (2017).","journal-title":"J. Neurol."},{"key":"305_CR11","doi-asserted-by":"publisher","unstructured":"Martinez-Martin, P. et al. Gender-related differences in the burden of non-motor symptoms in Parkinson\u2019s disease. J. Neurol. https:\/\/doi.org\/10.1007\/s00415-011-6392-3 (2012).","DOI":"10.1007\/s00415-011-6392-3"},{"key":"305_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1212\/WNL.0000000000000017","volume":"82","author":"AW Willis","year":"2014","unstructured":"Willis, A. W. et al. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology 82, 163\u2013171 (2014).","journal-title":"Neurology"},{"key":"305_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.parkreldis.2010.12.002","volume":"17","author":"GM Hariz","year":"2011","unstructured":"Hariz, G. M. et al. Gender distribution of patients with Parkinson\u2019s disease treated with subthalamic deep brain stimulation; a review of the 2000-2009 literature. Parkinsonism Relat. Disord. 17, 146\u2013149 (2011).","journal-title":"Parkinsonism Relat. Disord."},{"key":"305_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41582-019-0294-x","volume":"16","author":"S Meoni","year":"2020","unstructured":"Meoni, S., Macerollo, A. & Moro, E. Sex differences in movement disorders. Nat. Rev. Neurol. 16, 84\u201396 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"305_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0820-7","volume":"17","author":"L Dinkelbach","year":"2017","unstructured":"Dinkelbach, L., M\u00f6ller, B., Witt, K., Schnitzler, A. & S\u00fcdmeyer, M. How to improve patient education on deep brain stimulation in Parkinson\u2019s disease: the CARE Monitor study. BMC Neurol. 17, 36 (2017).","journal-title":"BMC Neurol."},{"key":"305_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/ane.12127","volume":"128","author":"GM Hariz","year":"2013","unstructured":"Hariz, G. M. et al. Gender differences in quality of life following subthalamic stimulation for Parkinson\u2019s disease. Acta Neurol. Scand. 128, 281\u2013285 (2013).","journal-title":"Acta Neurol. Scand."},{"key":"305_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.parkreldis.2006.12.013","volume":"13","author":"L Morgante","year":"2007","unstructured":"Morgante, L. et al. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat. Disord. 13, 528\u2013531 (2007).","journal-title":"Parkinsonism Relat. Disord."},{"key":"305_CR18","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.hrthm.2015.03.031","volume":"12","author":"PD Bhave","year":"2015","unstructured":"Bhave, P. D., Lu, X., Girotra, S., Kamel, H. & Vaughan Sarrazin, M. S. Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm 12, 1406\u20131412 (2015).","journal-title":"Heart Rhythm"},{"key":"305_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/jwh.2012.4107","volume":"22","author":"DE Feldman","year":"2013","unstructured":"Feldman, D. E. et al. Gender and other disparities in referral to specialized heart failure clinics following emergency department visits. J. Women\u2019s Health (Larchmt.) 22, 526\u2013531 (2013).","journal-title":"J. Women\u2019s Health (Larchmt.)"},{"key":"305_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1017\/S0317167100004698","volume":"33","author":"M Setiawan","year":"2006","unstructured":"Setiawan, M. et al. Referrals for movement disorder surgery: under-representation of females and reasons for refusal. Can. J. Neurol. Sci. 33, 53\u201357 (2006).","journal-title":"Can. J. Neurol. Sci."},{"key":"305_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00415-010-5814-y","volume":"258","author":"T W\u00e4chter","year":"2011","unstructured":"W\u00e4chter, T., M\u00ednguez-Castellanos, A., Valldeoriola, F., Herzog, J. & Stoevelaar, H. A tool to improve pre-selection for deep brain stimulation in patients with Parkinson\u2019s disease. J. Neurol. 258, 641\u2013646 (2011).","journal-title":"J. Neurol."},{"key":"305_CR22","doi-asserted-by":"publisher","unstructured":"Chibber, T. & Baranchuk, A. Sex-Related Differences in Catheter Ablation for Patients With Atrial Fibrillation and Heart Failure. Front. Cardiovasc. Med. 7, https:\/\/doi.org\/10.3389\/fcvm.2020.614031 (2020).","DOI":"10.3389\/fcvm.2020.614031"},{"key":"305_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/eurheartj\/ehp493","volume":"31","author":"A Hvelplund","year":"2010","unstructured":"Hvelplund, A. et al. Women with acute coronary syndrome are less invasively examined and subsequently less treated than men. Eur. Heart J. 31, 684\u2013690 (2010).","journal-title":"Eur. Heart J."},{"key":"305_CR24","first-page":"141","volume":"21","author":"AH Herold","year":"1997","unstructured":"Herold, A. H. et al. Evidence of gender bias in patients undergoing flexible sigmoidoscopy. Cancer Detect Prev. 21, 141\u2013147 (1997).","journal-title":"Cancer Detect Prev."},{"key":"305_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma, C. A. et al. Gender differences in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 78, 819\u2013824 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"305_CR26","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/mds.21520","volume":"22","author":"E Accolla","year":"2007","unstructured":"Accolla, E. et al. Gender differences in patients with Parkinson\u2019s disease treated with subthalamic deep brain stimulation. Mov. Disord. 22, 1150\u20131156 (2007).","journal-title":"Mov. Disord."},{"key":"305_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.parkreldis.2019.09.027","volume":"68","author":"R Kim","year":"2019","unstructured":"Kim, R. et al. Sex differences in the short-term and long-term effects of subthalamic nucleus stimulation in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 68, 73\u201378 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"305_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.parkreldis.2009.10.007","volume":"16","author":"A Hand","year":"2010","unstructured":"Hand, A., Gray, W. K., Chandler, B. J. & Walker, R. W. Sexual and relationship dysfunction in people with Parkinson\u2019s disease. Parkinsonism Relat. Disord. 16, 172\u2013176 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"305_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00415-009-5381-2","volume":"257","author":"LM Romito","year":"2010","unstructured":"Romito, L. M., Contarino, F. M. & Albanese, A. Transient gender-related effects in Parkinson\u2019s disease patients with subthalamic stimulation. J. Neurol. 257, 603\u2013608 (2010).","journal-title":"J. Neurol."},{"key":"305_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/0972-2327.128557","volume":"17","author":"S Chandran","year":"2014","unstructured":"Chandran, S. et al. Gender influence on selection and outcome of deep brain stimulation for Parkinson\u2019s disease. Ann. Indian Acad. Neurol. 17, 66\u201370 (2014).","journal-title":"Ann. Indian Acad. Neurol."},{"key":"305_CR31","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1093\/brain\/awaa234","volume":"143","author":"C Tremblay","year":"2020","unstructured":"Tremblay, C. et al. Sex effects on brain structure in de novo Parkinson\u2019s disease: a multimodal neuroimaging study. Brain 143, 3052\u20133066 (2020).","journal-title":"Brain"},{"key":"305_CR32","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1016\/S0140-6736(19)30651-8","volume":"393","author":"GR Gupta","year":"2019","unstructured":"Gupta, G. R. et al. Gender equality and gender norms: framing the opportunities for health. Lancet 393, 2550\u20132562 (2019).","journal-title":"Lancet"},{"key":"305_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-89","volume":"14","author":"K Hamberg","year":"2014","unstructured":"Hamberg, K. & Hariz, G. M. The decision-making process leading to deep brain stimulation in men and women with parkinson\u2019s disease - an interview study. BMC Neurol. 14, 89 (2014).","journal-title":"BMC Neurol."},{"key":"305_CR34","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.brs.2020.09.019","volume":"13","author":"HS Dafsari","year":"2020","unstructured":"Dafsari, H. S. et al. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson\u2019s disease. Brain Stimul. 13, 1697\u20131705 (2020).","journal-title":"Brain Stimul."},{"key":"305_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/0962280210394483","volume":"21","author":"E Williamson","year":"2012","unstructured":"Williamson, E., Morley, R., Lucas, A. & Carpenter, J. Propensity scores: from naive enthusiasm to intuitive understanding. Stat. Methods Med. Res. 21, 273\u2013293 (2012).","journal-title":"Stat. Methods Med. Res."},{"key":"305_CR36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/jpm11080773","volume":"11","author":"L Valentina","year":"2021","unstructured":"Valentina, L. et al. Personalised Advanced Therapies in Parkinson\u2019s Disease: The Role of Non-Motor Symptoms Profile. J. Pers. Med. 11, 773 (2021).","journal-title":"J. Pers. Med."},{"key":"305_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JPD-202278","volume":"11","author":"ST Jost","year":"2021","unstructured":"Jost, S. T. et al. Subthalamic stimulation improves quality of sleep in parkinson disease: a 36-month controlled study. J. Parkinsons Dis. 11, 323\u2013335 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"305_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"305_CR39","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1002\/mds.20955","volume":"21","author":"AE Lang","year":"2006","unstructured":"Lang, A. E. et al. Deep brain stimulation: preoperative issues. Mov. Disord. 21, S171\u2013S196 (2006). Suppl 14.","journal-title":"Mov. Disord."},{"key":"305_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuroscience.2013.02.043","volume":"240","author":"E Florin","year":"2013","unstructured":"Florin, E. et al. Modulation of local field potential power of the subthalamic nucleus during isometric force generation in patients with Parkinson\u2019s disease. Neuroscience 240, 106\u2013116 (2013).","journal-title":"Neuroscience"},{"key":"305_CR41","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/08870449708406741","volume":"12","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R. & Hyman, N. The PDQ-8: development and validation of a short-form Parkinson\u2019s Disease Questionnaire. Psychol. Health 12, 805\u2013814 (1997).","journal-title":"Psychol. Health"},{"key":"305_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin, P., Rodriguez-Blazquez, C., Kurtis, M. M., Chaudhuri, K. R. & Group, N. V. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov. Disord. 26, 399\u2013406 (2011).","journal-title":"Mov. Disord."},{"key":"305_CR43","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0b013e318285c0ed","volume":"80","author":"A Storch","year":"2013","unstructured":"Storch, A. et al. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80, 800\u2013809 (2013).","journal-title":"Neurology"},{"key":"305_CR44","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/ner.12740","volume":"21","author":"H Salimi","year":"2018","unstructured":"Salimi, H. et al. Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson\u2019s Disease. Neuromodulation Technol. Neural Interface 21, 532\u2013540 (2018).","journal-title":"Neuromodulation Technol. Neural Interface"},{"key":"305_CR45","doi-asserted-by":"publisher","unstructured":"Claudia, L-O. et al. Evaluation of the effect of bilateral subthalamic nucleus deep brain stimulation on fatigue in Parkinson\u2019s Disease as measured by the non-motor symptoms scale. Br. J. Neurosurg. 1\u20134, https:\/\/doi.org\/10.1080\/02688697.2021.1961681 (2021).","DOI":"10.1080\/02688697.2021.1961681"},{"key":"305_CR46","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1136\/jnnp-2021-326131","volume":"92","author":"S Anna","year":"2021","unstructured":"Anna, S. Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease. J. Neurol. Neurosurgery Psychiatry 92, 1313\u20131318 (2021).","journal-title":"J. Neurol. Neurosurgery Psychiatry"},{"key":"305_CR47","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","volume":"22","author":"KR Chaudhuri","year":"2007","unstructured":"Chaudhuri, K. R. et al. The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: Results from an international pilot study. Mov. Disord. 22, 1901\u20131911 (2007).","journal-title":"Mov. Disord."},{"key":"305_CR48","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jnnp.2003.017509","volume":"75","author":"J Marinus","year":"2004","unstructured":"Marinus, J. et al. A short scale for the assessment of motor impairments and disabilities in Parkinson\u2019s disease: the SPES\/SCOPA. J. Neurol. Neurosurg. Psychiatry 75, 388\u2013395 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"305_CR49","doi-asserted-by":"publisher","unstructured":"Sauerbier, A. et al. Clinical Non-Motor Phenotyping of Black and Asian Minority Ethnic Compared to White Individuals with Parkinson\u2019s Disease Living in the United Kingdom. J. Parkinsons. Dis. https:\/\/doi.org\/10.3233\/JPD-202218 (2020).","DOI":"10.3233\/JPD-202218"},{"key":"305_CR50","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/ene.13773","volume":"26","author":"HS Dafsari","year":"2019","unstructured":"Dafsari, H. S. et al. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson\u2019s disease. Eur. J. Neurol. 26, 222\u2013e217 (2019).","journal-title":"Eur. J. Neurol."},{"key":"305_CR51","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"305_CR52","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/mds.22512","volume":"24","author":"SM van Rooden","year":"2009","unstructured":"van Rooden, S. M., Visser, M., Verbaan, D., Marinus, J. & van Hilten, J. J. Motor patterns in Parkinson\u2019s disease: a data-driven approach. Mov. Disord. 24, 1042\u20131047 (2009).","journal-title":"Mov. Disord."},{"key":"305_CR53","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov. Disord. 25, 2649\u20132653 (2010).","journal-title":"Mov. Disord."},{"key":"305_CR54","doi-asserted-by":"crossref","unstructured":"Smithson, M. Confidence intervals. (Sage, 2003).","DOI":"10.4135\/9781412983761"},{"key":"305_CR55","unstructured":"Thoemmes, F. Propensity Score Matching in SPSS. arXiv:1201.6385 (2012)."},{"key":"305_CR56","unstructured":"Stuart, E. A. & Rubin, D. B.Best practices in quasi-experimental designs. (Sage Publications, 2008)"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00305-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00305-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:15:00Z","timestamp":1669299300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00305-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1038\/s41531-022-00305-y","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"17 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.T.J. was funded by the Prof. Klaus Thiemann Foundation. L.S. reports no financial disclosures. A.R. has received honorarium from UCB and was supported by a grant from Medtronic. P.A.L. was funded by the SUCCESS-Program of the University of Marburg, the Parkinson\u2019s Foundation, and the Stiftung zur F\u00f6rderung junger Neurowissenschaftler. K.A. has received honoraria for educational meetings, travel and consultancy from Medtronic, St. Jude Medical and Boston Scientific. J.E. reports no financial disclosures. F.R. reports no financial disclosures. M.T.B. received speaker\u2019s honoraria from Medtronic, Boston Scientific, Abbott (formerly St. Jude), GE Medical, UCB, Apothekerverband K\u00f6ln e.V. and Bial as well as research funding from the Felgenhauer-Stiftung, Forschungspool Klinische Studien (University of Cologne), Horizon 2020 (Gondola), Medtronic (ODIS), and Boston Scientific and advisory honoraria for the IQWIG. G.R.F. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)\u2014Project-ID 431549029\u2014SFB 1451. G.R.F. serves as an editorial board member of Cortex, Neurological Research and Practice, NeuroImage: Clinical, Zeitschrift f\u00fcr Neuropsychologie, and DGNeurologie; receives royalties from the publication of the books Funktionelle MRT in Psychiatrie und Neurologie, Neurologische Differentialdiagnose, and SOP Neurologie; receives royalties from the publication of the neuropsychological tests KAS and K\u00f6pps; received honoraria for speaking engagements from Bayer, Desitin, DGN, Ergo DKV, Forum f\u00fcr medizinische Fortbildung FomF GmbH, GSK, Medica Academy Messe D\u00fcsseldorf, Medicbrain Healthcare, Novartis, Pfizer, and Sport\u00e4rztebund NRW. Jeremy Franklin reports no financial disclosures. A.S. is funded by the Gusyk program and the Advanced Cologne Clinician Scientist program of the Medical Faculty of the University of Cologne and has received funding from the Prof. Klaus Thiemann Foundation. C.N. is consultant for Brainlab and received speaker\u2019s honoraria. A.S. reports no financial disclosures. K.R.C. has received funding from Parkinson\u2019s UK, NIHR, UCB, and the European Union; he received honoraria from UCB, Abbott, Britannia, US Worldmeds, and Otsuka Pharmaceuticals; and acted as a consultant for AbbVie, UCB, and Britannia. A.A. reports personal consultancy fees from Zambon, AbbVie, Boehringer Ingelheim, GE, Neuroderm, Biogen, Bial, EVER Neuro Pharma, Therevance, Vectura grants from Chiesi Pharmaceuticals, Lundbeck, Horizon 2020 - PD_Pal Grant 825785, Ministry of Education University and Research (MIUR) Grant ARS01_01081, owns Patent WO2015110261-A1, owns shares from PD Neurotechnology Limited. L.T. reports grants, personal fees and non-financial support from SAPIENS Steering Brain Stimulation, Medtronic, Boston Scientific and St. Jude Medical. P.M-M. has received honoraria from National School of Public Health (ISCIII), Editorial Viguera and Takeda Pharmaceuticals for lecturing in courses; from Britannia for writing an article in their Parkinson\u2019s Disease Medical Journal-Kinetic; and from the International Parkinson and Movement Disorder Society (MDS) for management of the Program on Rating Scales. Grants: from the MDS for development and validation of the MDS-NMS. Monty Silverdale has received honoraria from Bial, Britannia and Medtronic. E.K. has received grants from the German Ministry of Education and Research, the German Parkinson- Fonds, the German Parkinson Society; honoraria from: Oticon GmbH, Hamburg, Germany; Lilly Pharma GmbH, Bad Homburg, Germany; Bernafon AG, Bern, Switzerland; Desitin GmbH, Hamburg, Germany. V.V.V. is a member of the advisory boards and reports consultancies for Medtronic, Boston Scientific and St. Jude Medical. She received a grant from SAPIENS Steering Brain Stimulation. H.S.D. reports funding of his work by the EU Joint Programme\u2014Neurodegenerative Disease Research (JPND), the Prof. Klaus Thiemann Foundation, the Felgenhauer Foundation, and the Koeln Fortune Program, and honoraria by Boston Scientific, Medtronic and Stadapharm. This paper presents independent research funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King\u2019s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}